Muscular Dystrophy

Tevard Biosciences Demonstrates Breakthrough Protein Restoration in Genetic Muscle and Heart Diseases

Tevard Biosciences Demonstrates Breakthrough Protein Restoration in Genetic Muscle and Heart Diseases

Tevard Biosciences presented preclinical data showing its tRNA-based therapy can restore 70% of functional proteins in Duchenne muscular dystrophy and dilated cardiomyopathy models, potentially enabling clinical advancement for genetic diseases affecting millions worldwide.

September 29, 2025
Tevard's tRNA Therapy Offers Promising Approach to Duchenne Muscular Dystrophy Treatment

Tevard's tRNA Therapy Offers Promising Approach to Duchenne Muscular Dystrophy Treatment

Tevard Biosciences demonstrated a breakthrough in treating Duchenne Muscular Dystrophy by restoring full-length dystrophin protein using suppressor tRNA therapy, potentially offering hope for patients with nonsense mutations.

May 14, 2025